Cortney Caudill - Oct 1, 2025 Form 3 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF OPERATING OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Oct 1, 2025
Transactions value $
$0
Form type
3
Date filed
10/6/2025, 05:14 PM
Next filing
Oct 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Caudill Cortney SVP, CHIEF OPERATING OFFICER C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO /s/ James R. Oehler, Attorney-in-Fact 2025-10-06 0002090209

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HALO Common Stock 7.67K Oct 1, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HALO Option to Purchase Common Stock Oct 1, 2025 Common Stock 89.2K $33.51 Direct F1
holding HALO Option to Purchase Common Stock Oct 1, 2025 Common Stock 11.3K $57.44 Direct F1
holding HALO Restricted Stock Unit Oct 1, 2025 Common Stock 28K $0.00 Direct F2
holding HALO Restricted Stock Unit Oct 1, 2025 Common Stock 10.7K $0.00 Direct F2
holding HALO Performance Stock Unit Oct 1, 2025 Common Stock 2.24K $0.00 Direct F3
holding HALO Performance Stock Unit Oct 1, 2025 Common Stock 9.25K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests one-fourth on such date and then vests 1/48th monthly thereafter.
F2 One-fourth of the original grant vests on such date and one-fourth vests annually thereafter. Represents a restricted stock unit award with no exercise price.
F3 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The Issuer awarded the reporting person performance-based vesting stock units ("PSUs") on February 23, 2024 that included a performance measurement period ending December 31, 2024. This PSU holding represents the Issuer's determination of the number of stock units that became eligible to vest based on performance for such performance period. The stock units remain subject to a service-based requirement through the third anniversary of the PSU grant date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney